Catalyst
Slingshot members are tracking this event:
AstraZeneca (AZN) announces receipt of FDA CRL regarding its high potassium drug ZS-9
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
AZN | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 17, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Zs-9, High Potassium, Crl